drugset / Trial / NCT00324454
Levetiracetam for Cramps, Spasticity and Neuroprotection in Motor Neuron Disease
Non-randomizedSingle-groupOpen-labelTreatment
Summary
Levetiracetam (Keppra) is used to treat partial onset seizures. Its biological effects suggest it might also be useful in treating 3 aspects of human motor neuron diseases (MNDs) for which no effective therapy exists: cramps, spasticity, and disease progression.
Timeline
- Start
- 2006-05
- Primary completion
- 2007-12
- Completion
- 2008-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Levetiracetam | Other / unclassified | 1500 mg | — |